Oncogenes and Tumor Suppressors
Program: Oral and Poster Abstracts
Type: Oral
Type: Oral
Sunday, December 6, 2015: 4:30 PM-6:00 PM
W308, Level 3
(Orange County Convention Center)
Moderators:
Tobias Neff, MD, Children's Hospital Colorado
and
Gang Huang, PhD, Cincinnati Children's Hospital Medical Center
Disclosures:
Neff: Epizyme:
Patents & Royalties: US Patent 62/026583 Dot1l Inhibition in Patients with MN1 High AML filed 7/2014 Coinventor: Tobias Neff
.
4:30 PM
4:45 PM
5:00 PM
5:15 PM
5:30 PM
5:45 PM
*signifies non-member of ASH